Related Experiment Videos
High-resolution computed tomography of pediatric pulmonary parenchymal disorders
1Department of Radiology, State University of New York, School of Medicine, Buffalo.
Insights
High-resolution computed tomography (HRCT) aids in diagnosing pediatric lung diseases, especially in high-risk children with unclear chest X-rays. HRCT also assesses disease severity and therapy effectiveness in conditions like cystic fibrosis.
Area of Science:
- Pediatric Pulmonology
- Diagnostic Imaging
- Thoracic Radiology
Background:
- The diagnostic utility of computed tomography (CT) in pediatric lung disease is expanding.
- Established indications exist for CT, particularly in immunocompromised or high-risk children.
Purpose of the Study:
- To review the established and evolving roles of CT in diagnosing pediatric lung diseases.
- To highlight HRCT's utility in specific clinical scenarios and identify areas for future research.
Main Methods:
- Review of current literature and clinical applications of CT in pediatric lung disease.
- Focus on high-resolution CT (HRCT) for diagnosis, disease severity assessment, and therapy evaluation.
Main Results:
- HRCT effectively detects and localizes disease in febrile, symptomatic children with normal or nonspecific chest radiographs, enabling earlier treatment.
- HRCT assesses disease severity in bronchiectasis and cystic fibrosis, offering a sensitive method for evaluating treatment response.
- Ongoing research areas include infection effects on developing lungs, bronchopulmonary dysplasia quantification, asthma complications, and pulmonary edema assessment.
Conclusions:
- CT, particularly HRCT, is a valuable tool in pediatric lung disease diagnosis and management.
- Technological advancements, such as decreased scan times and dynamic scanning, will broaden CT's application in younger and more critically ill children.
- Future research will further define CT's role in various pediatric respiratory conditions and air trapping assessment.
Abstract:
The role of CT in the diagnosis of pediatric lung disease is still evolving, but certain indications are already well established. In immunocompromised or other high-risk children who have fevers or respiratory symptoms but normal or nonspecific chest radiographs, HRCT can detect and localize disease, thus allowing earlier therapy. It also has been shown that HRCT can assess the severity of disease in bronchiectasis and cystic fibrosis and that it may provide a more sensitive means of evaluating therapy in these conditions. Areas for research include the effects of infection on the developing lung, quantification of bronchopulmonary dysplasia, the prevalence of complications in asthma, and the use of HRCT in pulmonary edema of all types. As CT scan times decrease, the use of CT will expand to younger, sicker, and less cooperative children. Dynamic scanning probably will develop to provide a more accurate assessment of the focal and generalized air trapping that accompanies many common pediatric diseases.